4.6 Article

Transcellular blood-brain barrier disruption in malaria-induced reversible brain edema

Journal

LIFE SCIENCE ALLIANCE
Volume 5, Issue 6, Pages -

Publisher

LIFE SCIENCE ALLIANCE LLC
DOI: 10.26508/lsa.202201402

Keywords

-

Categories

Funding

  1. Olympia Morata Fellowship of the Medical Faculty of the University of Heidelberg
  2. German Centre for Infection Research (Deutsches Zentrum fuer Infektionsforschung, DZIF)
  3. National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) [U19AI089676]
  4. UK Medical Research Council [MR/S009450/1]
  5. NIH [R21AI142472]
  6. Deutsche Forschungsgemeinschaft [SFB1129]

Ask authors/readers for more resources

This study shows that reversible brain swelling in experimental murine cerebral malaria (CM) can be induced reliably after single vaccination with radiation-attenuated sporozoites, and it is suggested that transcellular blood-brain barrier disruption (BBBD) is responsible for the brain swelling. Although brain swelling can be reversed, it does not prevent persistent focal brain damage in the areas of most severe BBBD.
Brain swelling occurs in cerebral malaria (CM) and may either reverse or result in fatal outcome. It is currently unknown how brain swelling in CM reverses, as brain swelling at the acute stage is difficult to study in humans and animal models with reliable induction of reversible edema are not known. In this study, we show that reversible brain swelling in experimental murine CM can be induced reliably after single vaccination with radiation-attenuated sporozoites as proven by in vivo high-field magnetic resonance imaging. Our results provide evidence that brain swelling results from transcellular blood-brain barrier disruption (BBBD), as revealed by electron microscopy. This mechanism enables reversal of brain swelling but does not prevent persistent focal brain damage, evidenced by microhemorrhages, in areas of most severe BBBD. In adult CM patients magnetic resonance imaging demonstrate microhemorrhages in more than one third of patients with reversible edema, emphasizing similarities of the experimental model and human disease. Our data suggest that targeting transcellular BBBD may represent a promising adjunct therapeutic approach to reduce edema and may improve neurological outcome.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available